IDEXX Laboratories, Inc. (LON:0J8P)
London
· Delayed Price · Currency is GBP · Price in USD 408.18
-9.78 (-2.34%)
Mar 13, 2025, 7:18 PM BST
IDEXX Laboratories Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 3,898 | 3,661 | 3,367 | 3,215 | 2,707 | Upgrade
|
| Revenue Growth (YoY) | 6.46% | 8.72% | 4.73% | 18.79% | 12.45% | Upgrade
|
| Cost of Revenue | 1,519 | 1,471 | 1,363 | 1,326 | 1,136 | Upgrade
|
| Gross Profit | 2,379 | 2,190 | 2,004 | 1,889 | 1,571 | Upgrade
|
| Selling, General & Admin | 969.3 | 901.89 | 850.75 | 796.4 | 735.27 | Upgrade
|
| Research & Development | 219.79 | 190.95 | 254.82 | 161.01 | 141.25 | Upgrade
|
| Operating Expenses | 1,189 | 1,093 | 1,106 | 957.4 | 876.52 | Upgrade
|
| Operating Income | 1,190 | 1,097 | 898.77 | 932.03 | 694.52 | Upgrade
|
| Interest Expense | -31.21 | -41.58 | -39.86 | -29.81 | -33.13 | Upgrade
|
| Interest & Investment Income | 12.7 | 5.63 | 1.07 | 0.43 | 0.59 | Upgrade
|
| EBT Excluding Unusual Items | 1,171 | 1,061 | 859.97 | 902.65 | 661.99 | Upgrade
|
| Legal Settlements | -61.5 | - | - | - | - | Upgrade
|
| Pretax Income | 1,110 | 1,061 | 859.97 | 902.65 | 661.99 | Upgrade
|
| Income Tax Expense | 221.96 | 216.13 | 180.88 | 157.81 | 79.85 | Upgrade
|
| Earnings From Continuing Operations | 887.87 | 845.04 | 679.09 | 744.84 | 582.13 | Upgrade
|
| Minority Interest in Earnings | - | - | - | 0 | -0.36 | Upgrade
|
| Net Income | 887.87 | 845.04 | 679.09 | 744.85 | 581.78 | Upgrade
|
| Net Income to Common | 887.87 | 845.04 | 679.09 | 744.85 | 581.78 | Upgrade
|
| Net Income Growth | 5.07% | 24.44% | -8.83% | 28.03% | 36.02% | Upgrade
|
| Shares Outstanding (Basic) | 82 | 83 | 84 | 85 | 85 | Upgrade
|
| Shares Outstanding (Diluted) | 83 | 84 | 85 | 87 | 87 | Upgrade
|
| Shares Change (YoY) | -0.87% | -0.74% | -2.28% | -0.17% | -0.94% | Upgrade
|
| EPS (Basic) | 10.77 | 10.17 | 8.12 | 8.74 | 6.82 | Upgrade
|
| EPS (Diluted) | 10.67 | 10.06 | 8.03 | 8.60 | 6.71 | Upgrade
|
| EPS Growth | 6.06% | 25.28% | -6.63% | 28.17% | 37.22% | Upgrade
|
| Free Cash Flow | 808.08 | 772.88 | 394.15 | 636 | 541.11 | Upgrade
|
| Free Cash Flow Per Share | 9.71 | 9.20 | 4.66 | 7.35 | 6.24 | Upgrade
|
| Gross Margin | 61.04% | 59.82% | 59.52% | 58.76% | 58.04% | Upgrade
|
| Operating Margin | 30.53% | 29.97% | 26.69% | 28.99% | 25.66% | Upgrade
|
| Profit Margin | 22.78% | 23.08% | 20.17% | 23.17% | 21.49% | Upgrade
|
| Free Cash Flow Margin | 20.73% | 21.11% | 11.71% | 19.78% | 19.99% | Upgrade
|
| EBITDA | 1,320 | 1,212 | 1,011 | 1,037 | 790.52 | Upgrade
|
| EBITDA Margin | 33.86% | 33.11% | 30.01% | 32.24% | 29.21% | Upgrade
|
| D&A For EBITDA | 129.94 | 114.91 | 111.9 | 104.6 | 96 | Upgrade
|
| EBIT | 1,190 | 1,097 | 898.77 | 932.03 | 694.52 | Upgrade
|
| EBIT Margin | 30.53% | 29.97% | 26.69% | 28.99% | 25.66% | Upgrade
|
| Effective Tax Rate | 20.00% | 20.37% | 21.03% | 17.48% | 12.06% | Upgrade
|
| Revenue as Reported | 3,898 | 3,661 | 3,367 | 3,215 | 2,707 | Upgrade
|
| Advertising Expenses | 3.4 | 4.2 | 5 | 3.3 | 1.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.